All In MedTech

Device Trial Radar · NCT02363842

Trial Comparing SOC +Skin IQ MCM vs SOC for Pressure Ulcer (PU)

A Randomized, Controlled Trial Assessing Use of Skin IQ™ MCM Compared to Current Standard of Care for the Management of Moisture and Temperature at the Patient/Surface Interface for Prevention of Pressure Ulcer Development

Last checked: Nov 20, 2026Latest source record: Aug 14, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

160

Planned (sponsor's estimate)

Start

Apr 2015

Primary completion

Feb 2016

Study completion Feb 2016

Sponsor

Lead sponsor
ArjohuntleighNot on our public-company list
Sponsor type
Industry
Collaborators
Magellan Medical Technology Consultants, Inc.
First posted
Feb 16, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is a multi-center, prospective, randomized, controlled, clinical study evaluating the effects of microclimate management using Skin IQ™ MCM coverlet placed over commercially available pressure redistribution surfaces compared to standard of care (SOC). The objective of this study is to evaluate if a commercially available pressure redistribution surface when combined with the Skin IQ™ MCM coverlet will significantly reduce pressure ulcer (PU) incidence as compared to use of a commercially available pressure redistribution surface by itself by decreasing the effects of excessive moisture and temperature at the skin and surface interface.

Conditions

  • Pressure Ulcer

Interventions

  • Skin IQ™ MCM CoverletDevice

    Test article is the Skin IQ™ MCM, a Class II 510k exempt product. It is an overlay coverlet indicated to be used in conjunction with a pressure redistribution surface in order to aid in the prevention and treatment of skin breakdown and pressure ulcers for patients who require microclimate management of the skin.

  • Pressure redistribution surfaceOther

    Standard of Care (SOC): pressure redistribution surface already in use at the participating institution to manage patients at risk for tissue breakdown

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Pressure Ulcer developmentTime frame: Up to 60 days for incidence of Pressure Ulcer development

Locations

4 sites in 2 countries. Site status is shown where the registry gives one.

  • Integris Baptist Medical Center

    Oklahoma City, Oklahoma · Recruiting

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.